Constitutive Activity
Constitutive Activity - Related Videos
02:18
Constitutional Isomers of Alkanes
0 Views •
2023
Organic compounds of the same molecular formula can have different structural formulas called constitutional isomers, and the phenomenon is known as constitutional isomerism. Alkanes with four or more carbons showing multiple structures with the same molecular formula thereby exhibit constitutional isomerism. The linear isomer of an alkane is prefixed by the term “n”; hence a linear isomer of pentane is known as n-pentane. Based on the type of branching, some of the branched isomers are given...
01:27
Constitutive and Regulated Gene Expression
0 Views •
2025
Gene expression in prokaryotes is governed by constitutive and regulated systems, allowing cells to balance the production of essential proteins with adaptive responses to environmental changes.Constitutive Gene ExpressionConstitutive, or housekeeping, genes are continuously expressed as they encode proteins vital for fundamental cellular processes. These include enzymes for glycolysis, ribosomal components for protein synthesis, and proteins involved in DNA replication. Their constant...
10:03
Development of Leishmania Species Strains with Constitutive Expression of eGFP
0 Views •
2023
Here, we describe the methodology used for generating L. panamensis and L. donovani strains expressing the gene for eGFP as a stable integrated transgene using the pLEXSY system. Transfected parasites were cloned by limiting dilution, and clones with the highest fluorescence intensity in both species were selected for further use in drug screening assays.
09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
0 Views •
Cited by 41 •
2018
Targeted next-generation sequencing is a time- and cost-efficient approach that is becoming increasingly popular in both disease research and clinical diagnostics. The protocol described here presents the complex workflow required for sequencing and the bioinformatics process used to identify genetic variants that contribute to disease.
11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
0 Views •
Cited by 10 •
2011
A method for estimating the affinity constant of an agonist for the active state (Kb) of a G protein-coupled receptor is described. The analysis provides absolute or relative measures of Kb depending on whether constitutive receptor activation is measurable. Our method applies to various responses downstream from receptor activation.
FAQs
The balance between active and inactive receptor conformations determines basal signaling in the absence of ligand. Receptors that more frequently sample or stabilize active states can produce stronger baseline responses, making their behavior different from receptors that remain predominantly inactive. This conformational perspective helps explain why drugs may alter signaling even when no agonist is present.
Inverse agonists reduce basal signaling because they preferentially bind and stabilize inactive receptor states. Neutral antagonists, in contrast, block agonist-driven responses without changing the receptor’s existing basal activity. Distinguishing these actions is important when interpreting drug effects, since a reduced response may reflect suppression of constitutive activity rather than simple prevention of agonist binding or signaling.
Receptor mutations and expression levels can alter constitutive activity by changing how much signaling the system generates under ligand-free conditions. These variables may therefore influence the apparent effects of drugs, including whether an inverse agonist produces a measurable reduction in basal signaling. Controlling or comparing them helps researchers characterize receptor function more accurately.
Researchers assess constitutive activity by measuring signaling under ligand-free conditions and examining the response to drugs that act on the receptor. A decrease produced by an inverse agonist supports the presence of basal activity, whereas unchanged basal signaling with blockade of ligand responses is consistent with neutral antagonism. Such comparisons help separate receptor activity from agonist-evoked effects.
These measurements reveal how much receptor signaling occurs before an agonist is added and whether a drug changes that baseline. The results can help characterize receptor function, identify inverse agonism, and distinguish it from simple antagonism. They also provide a way to evaluate how receptor mutations or expression levels influence pharmacological responses.
Accounting for basal receptor signaling improves interpretation of drugs that target G protein-coupled receptors and other signaling proteins. A compound may suppress existing activity, merely block ligand responses, or enhance signaling relative to the receptor’s baseline. Recognizing these distinctions supports clearer pharmacological characterization and informs the development of drugs with more precisely understood effects.